Across TCGA patient cohorts, ABHD16A mutation is significantly associated with the RNA expression of many other genes, with 1,938 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ABHD16A-associated genes across cancer lineages are MAP7D1, ITGB1BP1, and NTAN1. Each is linked with ABHD16A in more than 1 cancer types. Because this analysis shows association rather than direction, both ABHD16A-to-partner and partner-to-ABHD16A results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ABHD16A→partner) and Y-score (partner→ABHD16A) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	MAP7D1 →	+0.703	+3.328	<.001	.005	3	2
SKCM	ITGB1BP1 →	+0.555	+3.353	.003	.005	3	2
UCEC	NTAN1 →	+0.595	+3.831	<.001	<.001	3	2
BLCA	RNU6-768P →	+0.868	+4.814	<.001	.003	3	2
SKCM	LINC02839 →	+0.116	+3.873	<.001	<.001	3	2
BRCA	SNORD111B →	+0.523	+4.859	.007	.002	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 1,938 associations by consensus.

Exploration

ABHD16A survival (RNA) · tumor vs normal (RNA) · all ABHD16A data types